Organization Overview
The Coller Laboratory is devoted primarily to investigating platelet physiology, thrombosis, vascular biology, and adhesion phenomena in sickle cell disease. Studying the basic molecular interactions between blood cells and the blood vessel, the lab s research spans from basic molecular structure to complex phenomena such as thrombosis in intact animals, with the goal of using knowledge of these molecular interactions to develop new therapies for thrombosis and sickle cell disease.In addition to its basic and translational research programs, the laboratory plays a leadership role in several university-wide initiatives focused on infectious disease and community-engaged clinical research. Dr. Barry Coller serves as Co-Director of The Rockefeller University-Stavros Niarchos Foundation (SNF) Institute for Global Infectious Disease Research and Director of the Rockefeller University Center for Clinical and Translational Science (RU-CCTS).The Rockefeller University - Stavros Niarchos Foundation (SNF) Institute for Global Infectious Disease Research is led by Dr. Charles Rice, who shared the Nobel Prize for Physiology or Medicine in 2020 for foundational research that led to the development of a therapeutic for Hepatitis C. The Institute is co-led by Drs. Michel Nussenzweig and Barry Coller. The Rockefeller University Center for Clinical and Translational Science (RU-CCTS), led by Dr. Coller, has a Community Engaged Research Core co-directed by Dr. Jonathan N. Tobin, a cardiovascular epidemiologist who conducts community-based comparative effectiveness and implementation research at Clinical Directors Network (CDN), the national practice-based research (PBRN) that he leads, which works with Federally Qualified Health Centers (FQHCs) and other safety-net practices that serve communities experiencing significant health and social disparities.RU-CCTS and CDN have developed an approach to conducting highly community-engaged research that examines epidemiology and outcomes in community-based settings, while embedding basic science/mechanistic assays. This team has successfully conducted a series of highly stakeholder-engaged studies on the epidemiology, treatment patterns and outcomes for patients presenting to CDN FQHCs with skin and soft tissue infections (SSTIs) caused by Staphylococcus aureus (MRSA and MSSA). This community-academic "full spectrum translational research" team will apply the model to Chagas disease developed during the MRSA. Chagas disease is an emerging infectious disease in the USA, primarily affecting individuals and communities from Latin America, where the disease is endemic.
Overview
We seek an advanced Postdoctoral researcher to add additional research perspectives and methods to this team. This is a great opportunity for an exceptional individual interested in studying population health models of Chagas Disease and other emerging infectious diseases with significant associated morbidity and mortality. Chagas disease primarily affects migrants, refugees and immigrants from Latin America, and domestic transmission in the USA is also increasing. The combined rich environment of Rockefeller, CDN and FQHCs provides opportunities for participating in practice-based research and service-learning within both academic and community-based settings and will offer a unique and unparalleled opportunity for the Fellow to develop a focus within the larger Chagas Disease project that will accelerate his/her career development. We look forward to identifying an outstanding candidate who brings a unique skill set to the team that will broaden the translational research perspective while building new and valuable research and communications skills. We strive to build a supportive culture in our endeavors. More information can be found
at https://www.rockefeller.edu/research/community-engagement/ and www.CDNetwork.org/chagas.
Appointment Term: This is a one-year appointment with the possibility of extension, not to exceed 18 months in total.
Responsibilities
Responsibilities include:
Qualifications
REQUIRED QUALIFICATIONS:
PREFERRED QUALIFICATIONS:
The Rockefeller University is an equal opportunity employer - veterans/individuals with disabilities. Qualified applicants will receive consideration for employment without regard to characteristics protected by applicable local, state or federal law, including but not limited to disability and protected veteran status.
The salary of the finalist selected for this role will be set based on various factors, including but not limited to organizational budgets, qualifications, experience, education, licenses, specialty, and training. The hiring range provided represents The Rockefeller University s good faith and reasonable estimate of the range of possible compensation at the time of posting.
Compensation Range: Min
USD $72,100.00/Yr.
Compensation Range: Max
USD $72,100.00/Yr.